Anaptysbio Inc (ANAB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ANAB Annual Balance Sheets →
Tracking balance sheet results across Anaptysbio Inc to Mar 31 2025 helps illustrate how Mar 31 2026's financial position has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent248.47
Available-for-sale Securities, Debt Securities, Current MA37.99
Cash & Short-term Investments285.00
Accounts receivable25.75
Prepaid Expense And Other Assets Current3.91
Total Current Assets316.11
Equipment/Property/Plant Net1.28
Long-term investments0.00
Other Assets, Noncurrent12.30
Operating Lease Right Of Use Asset12.04
Total Assets329.68
Liabilities
Accounts Payable, Current AC7.52
Accrued Liabilities, Current AC32.07
Other Liabilities, Current0.00
Total Current Liabilities41.70
Total Long-term Debt0.00
Operating Lease Liability Current2.12
Total Liabilities316.94
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock838.31
Retained Earnings / Accumulated Deficit-825.44
Other Equity-0.15
Common Stockholder's Equity12.75
Total Stockholder's Equity12.75
Liabilities & Stockholder's Equity329.68
4 historic quarters locked

Sign in to unlock the full Anaptysbio Inc balance sheet history.

About Anaptysbio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-219515

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.